Franklin Resources, Inc. 13D and 13G filings for Iovance Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-04 2:25 pm Sale |
2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
FRANKLIN RESOURCES INC BEN |
5,797,716 3.700% |
-3,131,188 (-35.07%) |
Filing |
| 2021-02-01 5:05 pm Purchase |
2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
FRANKLIN RESOURCES INC BEN |
8,928,904 6.100% |
3,451,148 (+63.00%) |
Filing |